UNSPSC 51392210: Medetomidine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392210

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MR15E85MQM, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)- but generally known as medetomidine, which bears US NIH Compound Identifier 68602. European Medicines Agency schedules Medetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08691MIG.

Read the full definition

The term MEDETOMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). MEDETOMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule medetomidine under HS 29332990 and SITC 51573. As of Q4 2014, MEDETOMIDINE remains the US FDA Preferred Term for this commodity. Medetomidine bears US NLM identifiers UMLS ID C0125656 and NCI Concept Code C81367. SMILES: CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.

About UNSPSC 51392210

UNSPSC 51392210 Medetomidine is a Commodity code that maps poorly to recent state and local procurement activity. The two most recent opportunities tagged under this code—a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs—involve naloxone (an opioid antagonist) and pharmacy benefit management respectively, neither of which aligns with medetomidine's pharmaceutical profile as a veterinary sedative and analgesic agent. The naloxone procurement is concrete and quantified (1,900 units of naloxone and 800 drug deactivation systems annually), while the Texas RFI is exploratory market research on prescription-fulfillment models with no specific product or service line named. State and local jurisdictions do not appear to be actively procuring medetomidine itself under this code at present.

The code shows minimal recent activity and no clear pattern of issuing bodies or geographic concentration. Seminole County's opportunity is classified as an IFB with a response deadline of July 26, 2023 (predating the current date), and the Texas HHS RFI closed April 3, 2026, with no forward procurement timeline identified. The mismatch between the code's pharmaceutical scope and the naloxone/pharmacy-management focus of the recent opportunities suggests either miscoding at the source or dormant procurement activity under the medetomidine classification. Business development professionals should verify the correct UNSPSC codes for target jurisdictions and commodity families before relying on this code for pipeline development.

Quick answers

What is UNSPSC 51392210?

UNSPSC 51392210 is Medetomidine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392210?

UNSPSC 51392210 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392210

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code